Article Details

CHRONIC KIDNEY DISEASES: AN OVERVIEW OF MANAGEMENT AND TREATMENT STRATEGIES

Harshad S. Kaparea *, Sohan S. Chitlangeb, Kaveri S. Aherb and Dheeraj H. Nagorec

a Department of Pharmaceutics, Dr. D. Y. Patil Unitech Society’s Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune - 411 018, Maharashtra, India

b Department of Quality Assurance Techniques, Dr. D. Y. Patil Unitech Society’s Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune - 411 018, Maharashtra, India

c Department of Pharmacognosy, Dr. D. Y. Patil Unitech Society’s Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune - 411 018, Maharashtra, India

*For Correspondence: E-mail: hskapare@yahoo.in

 

https://doi.org/10.53879/id.59.08.12991


ABSTRACT

Chronic kidney diseases (CKD) are an important public health concern worldwide. In developed as well in less-developed countries, prevalence of CKD is increasing day by day. Large numbers of people are affected by cost of care, dialysis and transplantation treatment strategies and lack of awareness in rural areas and implementation of treatment strategies. Primordial prevention of CKD can be achieved through implementation of measures to ensure healthy development by working on new treatment strategies, accepting new processes of prevention and covering gaps found during the previous data created. This review work is aimed to compile in depth literature on CKD; majorly relationship between acute kidney injuries (AKI), CKD and end stage renal disease (ESRD) causes and different stages of CKD, prevalence or epidemiology and global current status. Diagnosis parameters, current treatment strategies along with traditional medicines and new pipeline drugs on CKD are described in detail for prevention and treatment of CKD, along with gap analysis.

Year 2022 | Volume No. 59 | Issue No.8 | Page No. 7-20
Recent Issue
Current Issue
August 2022
Quick Contact